First Page | Document Content | |
---|---|---|
Date: 2015-02-04 05:15:01 | PRESS RELEASE – PRESSEINFORMATION GANYMED raises EUR 14.4 million in Series B Financing Round Mainz, Germany (July 06, 2005) – GANYMED Pharmaceuticals AG, a privately held antibody development company with a focus oAdd to Reading ListSource URL: www.ganymed-pharmaceuticals.comDownload Document from Source WebsiteFile Size: 45,77 KBShare Document on Facebook |